Evaluating the Efficacy and Safety of Roflumilast in Patients with NASH

Clinical trial NCT06677788 · COMPLETED

Trial details

NCT number: NCT06677788
Sponsor: Tanta University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Alcoholic Steatohepatitis (NASH)

Start date: 2022-04-01
Primary completion: 2024-09-20
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.